Cholesterol news and cholesterol widget
Wednesday, November 12, 2008 ( change date )
Statin Reduces Heart Attack, Stroke Rates In Patients With Normal Cholesterol But Elevated C-Reactive Protein
New data from the landmark ATHENA trial showed that dronedarone significantly reduced the incidence and total duration of hospital stays among patients with atrial fibrillation/atrial flutter (AF/AFL). This post-hoc analysis was presented at the 2008 American Heart Association Scientific Sessions in New Orleans, Louisiana. In this new analysis, dronedarone significantly reduced the total number of hospital days by 28 percent (p
Medicalnewstoday.com Wednesday, November 12, 2008Colesevelam HCl Lowered LDL Cholesterol In Pediatric Patients With Heterozygous Familial Hypercholesterolemia
Daiichi Sankyo, Inc. (DSI), announced that results from the pivotal study supporting the use of colesevelam HCl in pediatric patients with heterozygous familial hypercholesterolemia (heFH), were presented for the first time at the American Heart Association's (AHA) Annual Scientific Sessions 2008.
Medicalnewstoday.com Wednesday, November 12, 2008High Blood Fat Levels Tied to Ischemic Stroke Risk (HealthDay)
HealthDay - TUESDAY, Nov. 11 (HealthDay News) -- A Danish study links high
levels of the blood fats called triglycerides with an increased risk of
stroke -- and the way those levels were measured could change a basic
medical practice, one of the researchers says.
yahoo.com Wednesday, November 12, 2008Health Risks For Large, Retired Athletes May Be Lowered By Staying Active
Study highlights: Retired NFL players have fewer heart disease risk factors overall, but higher cholesterol and glucose levels. Physical activity may have prevented the development of higher rates of diabetes or greater amounts of atherosclerosis. Since today's players are 50 percent larger than 25 years ago, further study is needed on whether current players are at greater risk for cardiovascular events or death, researchers said.
Medicalnewstoday.com Wednesday, November 12, 2008VAP Cholesterol Test Identifies Treatment Effects Of Combination Therapy
Using the VAP Cholesterol Test from Atherotech, Inc., investigators led by Michel Farnier M.D., of Point Medical, Rond Point de la Nation, Dijon, France, have reported beneficial changes in lipoprotein subclasses and LDL particle size using combination therapy. The information could be helpful to physicians because of the known association between abnormal lipoprotein subfractions and increased cardiovascular risk in patients with mixed hyperlipidemia.
read more
Emax Health Wednesday, November 12, 2008
PREVIEW
OF YOUR NEWS WIDGET
INSTALL YOUR WIDGET